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ABSTRACT Recent advances in cancer research have identiﬁed critical angiogenic signaling pathways and the inﬂuence of the
extracellular matrix on endothelial cell migration. These ﬁndings provide us with insight into the process of angiogenesis that can
facilitate the development of effective computational models of sprouting angiogenesis. In this work, we present the ﬁrst three-
dimensionalmodel of sprouting angiogenesis that considers explicitly the effect of the extracellularmatrix and of the soluble aswell
asmatrix-bound growth factors on capillary growth. The computationalmodel relies on a hybrid particle-mesh representation of the
blood vessels and it introduces an implicit representation of the vasculature that can accommodate detailed descriptions of nutrient
transport. Extensive parametric studies reveal the role of the extracellular matrix structure and the distribution of the different
vascular endothelial growth factors isoforms on the dynamics and the morphology of the generated vascular networks.
INTRODUCTION
Sprouting angiogenesis, the process of new capillaries
forming from existing vessels, can be observed in the human
body under various conditions. Apart from angiogenesis in a
physiological context which mainly takes place during em-
bryogenesis and fetal development, angiogenesis can be
observed under pathological conditions, such as wound
healing, thrombosis, and tumor growth (1,2). In the case of
wound healing and thrombosis, newly formed capillaries
grow in a controlled manner and stop growing once the
pathological condition has been alleviated; this is, however,
not the case for tumor-induced angiogenesis (2).
Tumor-induced angiogenesis can persist for years, in-
volving a disorganized, inefﬁcient, and leaky vasculature (2).
This vasculature supplies the tumor with nutrients and
growth factors, enabling increased tumor cell proliferation
and thus enhanced tumor growth. Furthermore, angiogenesis
enables hematogenous spread of cancer: single cancer cells
or cell clusters that detach from the primary tumor may enter
the leaky vessels and use the vasculature to metastasize to
remote organs (3). The regulation or even inhibition of tu-
mor-induced angiogenesis can affect tumor growth. The in-
hibition of angiogenesis restrains nutrient supply, reducing
the growth rate of the tumor and hindering migrating cell
clusters from entering the vasculature, thus reducing the risk
of metastasis (3,4). A complete inhibition promotes hypoxia
(state of oxygen shortage) within the tumor that can increase
the occurrence of aggressive migrating tumor cell pheno-
types (5,6). The regulation of capillary growth may present a
more efﬁcient pathway for drug delivery, as the leaky vessels
and the high interstitial pressure in the proximity of the tumor
prevents effective supply of drugs through the blood vessels
into the core of the tumor (7). Although antiangiogenic
therapy is comparatively young, it has already been estab-
lished as the fourth pillar of cancer therapy (4), next to sur-
gery, radiation, and chemotherapy.
Tumor-induced sprouting angiogenesis
The maximal size a tumor can assume without relying on a
vasculature for nutrient supply is restricted to;1 mm3 (4,8).
In this stage of avascular growth, nutrients reach the tumor by
the sole means of diffusion through the surrounding tissue. If
the tumor grows beyond this size of;1mm3, cells in the core
of the tumor cannot obtain enough oxygen to survive. These
cells become hypoxic and eventually starve, forming a ne-
crotic region at the core of the tumor. Tumors can reside in
this avascular state for a long time (4). However, one of the
many responses of tumor cells to hypoxia and glucose dep-
rivation is that they start to secrete angiogenic growth factors
that are responsible for initiating sprouting angiogenesis (9).
Several growth factors are involved in the process of angio-
genesis. Vascular endothelial growth factors (VEGF) have
been identiﬁed to be one of the main driving forces (10).
VEGFs, upon release by hypoxic tumor cells, diffuse through
the extracellular matrix (ECM) occupying the space between
tumor and existing vasculature in the proximity of the tumor
and establish a chemical gradient between the tumor and nearby
vessels. Once VEGF has reached a vessel, it binds to receptors
located on endothelial cells (EC), which line the blood vessel
walls. This binding sets off a cascade of events (10–12).
In the early phase of angiogenesis, ECs stimulated by
VEGF start releasing proteases that degrade the basal lamina,
a ﬁbril structure building the outermost layer of the vessel
wall (1,13). This enables ECs to leave the vessel wall and
enter the ECM. Further intercellular and intracellular sig-
naling pathways, initially triggered by VEGF, increase EC
proliferation and coordinate the selection of migrating ECs
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located at the tip of outgrowing sprouts (1). Migrating sprout
tip cells probe their environment by extending ﬁlopodia and
migrate along the VEGF gradient toward regions of higher
concentration, a directed motion referred to as chemotaxis
(14). ECs located initially behind the migrating tip cells
proliferate, thus extending the sprouting blood vessel (1,14).
Fibronectin, which is distributed in the ECM and at the same
time released by the migrating tip cells, establishes an ad-
hesive gradient which serves as another cue for the ECs
following behind (13,15,16). Fibronectin released by the ECs
binds to matrix components such as collagens and other
ﬁbers, which occupy roughly 30% of the ECM (17). Matrix-
bound ﬁbronectin in turn can bind to transmembrane receptors
located on the EC membrane (18). This autocrine signaling
pathway, promoting cell-cell and cell-matrix adhesion, ac-
counts for a movement referred to as ‘‘haptotaxis’’ (1). In
addition to chemotactic and haptotactic cues, the ﬁbrous
structures present in the ECM also inﬂuence cell migration by
facilitating movement in ﬁber directions (19,20).
After the initial sprouts have extended for some small
distance into the ECM, repeated branching of the tips can be
observed. Sprout tips approaching others may fuse and form
loops, a process called ‘‘anastomosis’’. Anastomosis can be
observed to occur either by sprout tips fusing with other
sprout tips thus arresting their migration, or by sprout tips
fusing with already established sprouts at some distance be-
hind the tip. Along with anastomosis, the formation of lumen
within the strands of endothelial cells establishes a network
that allows blood circulation (1). Maturation, the ﬁnal stage
of angiogenesis, incorporates the rebuilding of a basal lamina
and the recruitment of pericytes and smooth muscle cells to
stabilize the vessel walls (21). In tumor-induced angiogene-
sis, the newly built vasculature is often disorganized and
leaky, leading to high interstitial pressure and inefﬁcient
blood supply (22). Together with a growing tumor, which
exerts pressure on the fragile capillaries and thus suppresses
temporal and local blood delivery, ever new regions of acute
hypoxia arise, releasing in turn VEGF, which sets off the
process of angiogenesis anew (23). This process does not
stop and full maturation is impaired (4).
Vascular endothelial growth factors
In addition to the soluble isoform of VEGF, several other
VEGF isoforms inﬂuence the capillary network formation
(24,25). Some VEGF isoforms express a binding site for
heparan sulfate proteoglycans which is found on cell sur-
faces, in the ECM, and in body ﬂuids. Such isoforms can
therefore be bound by the ECM (26). These matrix-bound
VEGF isoforms can be cleaved from the ECM by matrix
metalloproteinases (MMPs) (24) establishing localized che-
motactic cues. MMPs are expressed both by tumors and
migrating ECs (15,27). Inﬂammatory cells stimulated by the
tumor can also release VEGF and contribute to the chemo-
tactic cues of the ECs (28).
Extracellular matrix
The extracellular matrix describes the material between cells
in metazoans, including the space between the initial vas-
culature and the tumor and plays an important role in cell
migration. Fibers such as collagen, laminin, and ﬁbrillin are
distributed throughout the ECM occupying roughly 30% of
the ECM (17). These ﬁbers form bundles that serve as
guiding structures for migrating cells (13,19). The structures
are in turn subject to remodeling by endothelial tip cells (29),
facilitating migration through thematrix and playing a crucial
role in lumen formation (13). The ECM further presents
binding sites for ﬁbronectin and matrix-bound VEGF iso-
forms that can be cleaved by MMPs.
COMPUTATIONAL MODELING
OF ANGIOGENESIS
The modeling of vasculogenesis, the formation of blood
vessels during embryogenesis, and angiogenesis has gained
increased interest over the last 20 years. An increase in the
availability of biological data, along with increased compu-
tational capabilities has enabled the formulation and com-
putational exploration of these processes. In the following,
we provide a short overview of the modeling work done in
the ﬁeld of angiogenesis, distinguishing between two broad
model categories: 1), continuum models; and 2), discrete
models, including cellular automata, agent-based models,
and cellular Potts (CP) models. A comprehensive and more
detailed overview of mathematical modeling in the ﬁeld
of angiogenesis can be found in Mantzaris et al. (30) and in
the model comparison sheet (see Supplementary Material,
Data S1).
Continuum models
Continuum models aim to describe the large-scale, average
behavior of cell populations using a system of partial dif-
ferential equations. Accordingly, capillary networks are de-
scribed in terms of endothelial cell densities.
The work of Balding and McElwain (31) can be consid-
ered as the onset of continuum modeling of angiogenesis
using partial differential equations. In their work, they de-
scribe vascular networks by endothelial tip cell and sprout
cell densities, showing simulations of the outgrowth of net-
works in one dimension through the introduction of a che-
motactic stimulus. Byrne and Chaplain (32) then considered
one-dimensional systems of angiogenesis, which were ex-
tended to two dimensions and included effects of haptotaxis
as EC-Fibronectin interaction by Orme and Chaplain (33), as
well as Anderson and Chaplain (34,35).
The process of bud formation observable in the early stage
of angiogenesis was ﬁrst addressed mathematically by Orme
and Chaplain (36). In a one-dimensional domain, reaction-
diffusion dynamics and haptotaxis mechanisms lead to an
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aggregation of endothelial cells forming buds. Levine et al.
(37,38) presented models based on the continuum theory of
reinforced random walks (39), which described the incep-
tion of angiogenesis including accounting for macrophages
and pericytes involved in the process of vessel maturation.
The continuummodel equations are derived from enzymatic
Michaelis-Menten biochemical reactions. Levine et al. (40)
then coupled these one-dimensional models of bud forma-
tion to a two-dimensional model describing the migratory
response of endothelial cells within the ECM. This complex
model considers the dynamics of tumor angiogenesis factor,
protease enzymes, ﬁbronectin, and EC concentrations and
included the role of angiogenic inhibitors, namely angiostatin.
An extension to this model including a maturation process
for ECs and the dynamics of angiopoietin was presented by
Plank et al. (41). Mechano-chemical models of vasculogen-
esis and angiogenesis have been proposed by Manoussaki
et al. (42) and Holmes and Sleeman (43). In these models,
the ECM is represented as a viscoelastic material interacting
with the ECs.
Discrete models
Continuum models provide valuable insight into the pro-
cesses of angiogenesis but they are limited in their predic-
tion of the structure of vascular networks. To determine
the physiology that governs nutrient, oxygen, and drug
throughput of such networks, discrete models have been
presented, describing the morphology of vascular networks.
Discrete models are distinguished as cellular automata,
agent-based, and cellular Potts (CP) models. One of the ﬁrst
works describing angiogenesis as a discrete process was
introduced by Stokes and Lauffenburger (44). In this agent-
based model, a two-dimensional, lattice-free model deﬁnes
sprouts by the trace of individual tip cells and considers
branching to occur according to predeﬁned probabilistic
rules. Tip cell migration is governed by a stochastic dif-
ferential equation accounting for chemotaxis and random
motion. The lattice-based model presented by Anderson
and Chaplain (34) is derived from the discretization of a
two-dimensional continuum model. Tip cells located at
discrete lattice points are assigned probabilities to migrate
to adjacent lattice points within the next simulation time-
step. These probabilities account for chemotactic, hap-
totactic, and diffusive contributions corresponding to a
continuum formulation. Capillaries are represented as masked
points on the grid and probabilistic branching rules depend
on the sprout age, tumor angiogenesis factor concentration,
and the EC density. An extension to three dimensions is
presented in Chaplain (35). Sun et al. (45) present a deter-
ministic, two-dimensional model of angiogenesis. The ECM
is explicitly modeled by an anisotropic directional ﬁeld,
inﬂuencing EC migration and branching behavior. These
lattice-based models are based on the theory of cellular au-
tomata.
In the literature (46,47), mathematical modeling of ﬂow in
capillary networks has been presented in two- and three-di-
mensional networks, where blood is modeled as a non-
Newtonian ﬂuid. These works have been extended to deﬁne
an interactive description of blood pressure and shear stress
dependent vessel remodeling and branching during angio-
genesis (48,49). Tip cell migration is determined by
chemotaxis, haptotaxis, and random motion. Further, matrix-
degrading enzymes released by the ECs are considered to
degrade ﬁbronectin in the ECM. More recently discrete
agent-based models of angiogenesis have been coupled to
models of tumor growth, in two and three dimensions
(50,51). CP models were introduced in Glazier and Graner
(52) to simulate the adhesion-driven rearrangement of bio-
logical cells. CP models have been used to model vasculo-
genesis by Merks et al. (53) and angiogenesis by Bauer et al.
(54). In Bauer et al. (54), two-dimensional simulations of
angiogenesis are presented that employ ECM representation
consisting of structural cells, ﬁbers, and interstitial ﬂuid.
Endothelial cell migration is governed by chemotactic and
haptotactic stimuli, and branching and anastomosis occur in
response to cell-cell and cell-matrix interactions.
A hybrid model of sprouting angiogenesis
In this article, we present a deterministic, hybrid model of
sprouting angiogenesis. The model combines a continuum
approximation of VEGF,MMPs, ﬁbronectin, and endothelial
stalk cell density with a discrete, agent-based particle repre-
sentation for the tip cells. The particle representation of in-
dividual tip cells enables a grid-independent migration as
proposed in Plank and Sleeman (55). Particle-mesh interpo-
lation methods are employed to derive an implicit three-di-
mensional level-set representation of voluminous vessels.
This continuous, grid-independent formulation of the de-
veloping capillary network is an extension of the discrete
indicator functions considered in existing models. By mod-
eling lumen formation as an implicit process that takes place
during angiogenesis, we can derive tubular vessels that allow
for blood ﬂow simulations in complex geometries, the sub-
ject of ongoing research.
The chemotactic response of ECs to soluble VEGF gra-
dient is considered to be the key driving force of angiogenesis
in most mathematical models of sprouting angiogenesis.
However, the inﬂuence of matrix-bound VEGF isoforms on
the branching behavior of ECs (24,25) has not been consid-
ered in any model so far. Bauer et al. (54) present studies in
the presence of a nondiffusing isoform, distributed according
to the initial soluble VEGF proﬁle, but the model does not
consider the dynamics of protease-VEGF interactions that
play a key role in cleaving the matrix-bound isoform from the
ECM. Novelties in this work lie in the consideration of a
localized matrix-bound VEGF isoform and its cleaving by
proteases (MMPs) (Fig. 1) released at the endothelial tip cells
(see Vascular Endothelial Growth Factors). Studies are pre-
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sented that highlight the effects observable on the vessel
geometries.
Further, the model considers the explicit modeling of the
ECM by introducing randomly distributed ﬁber bundles to
inﬂuence EC migration and branching. This approach ren-
ders the model completely deterministic, removing the ran-
dom migration component on EC migration (35,55,56). Sun
et al. (45) addressed the ECM by a heterogeneous and ani-
sotropic description of conductivity. Similar to this model,
the ECM in the work presented herein acts as a tensor on the
migration cues given by the VEGF and ﬁbronectin gradients.
In Bauer et al. (54), an explicit formulation of the ECM
consisting of ﬁbers, structural cells, and interstitial ﬂuid is
introduced, inﬂuencing EC migration through adhesive
forces. This work additionally considers the ﬁbers to offer
binding sites for matrix-bound VEGF and ﬁbronectin, which,
to the best of our knowledge, has not been considered in
mathematical modeling work so far.
Branching is modeled to occur in response to divergence in
directional cues given by the VEGF and ﬁbronectin gradients
as well as the ECM ﬁber orientations. Filopodia are modeled
explicitly to sense the migration cues in the vicinity of the tip
cells, determining the branching direction. No branching
probabilities (34,35,55) are introduced. To account for the
cell cycle, the model assumes a threshold time span after a
branching event has taken place, before which a tip cell
cannot proliferate or branch. This is a common assumption
that has been included into existing models (34,35,55). Other
models that do not depend on probabilistic branching rules
are presented in Sun et al. (45) and Bauer et al. (54). In the
former, branching depends on the variation of the normal
velocity on the transverse tip cell orientation. In the later
model, branching occurs without any predeﬁned rule, solely
depending on diverging adhesive forces promoted by ECM
ﬁbers and structural cells.
HYBRID MODEL OF SPROUTING ANGIOGENESIS
We present the assumptions of the proposed model and their
respective computational implementation. This model
quantiﬁes several biological assumptions and their dynamic
interactions, thus enabling the identiﬁcation of critical factors
in the process of angiogenesis and paving the way for future
integration of experimental data (57). We note that these
assumptions do not address all the biological processes of
angiogenesis and that they may be more pertinent to in vitro
angiogenesis rather than in vivo angiogenesis, which is
known to depend on the particular microenvironment (58).
Model overview
This model of tumor-induced sprouting angiogenesis dis-
tinguishes molecular species and cells. We use a hybrid ap-
proach representing molecular species by their concentration
and migrating EC tip cells by particles. The evolution of
molecular species is governed by reaction-diffusion equa-
tions that are discretized on the grid while a particle approach
is employed to model the migrating EC tip cells. Newly
formed capillaries are in turn represented by the endothelial
cell density. The particle and grid descriptions are coupled as
the ECs both serve as a source of ﬁbronectin and MMPs and
as sink for VEGF (binding to the cell surface receptors). As
the tip cells migrate through the ECM following up the
chemotactic and haptotactic cues, they deﬁne the morphol-
ogy of the outgrowing sprouts. The migrating tip cells depose
ECs along their way leaving a trail of endothelial cell density
on the grid. From the voluminous three-dimensional repre-
sentation of the vessels, a level-set approach can easily be
employed to generate tubular structures capable of support-
ing blood ﬂow. The ECM is explicitly modeled to consist of
directed bundles of collagen ﬁbers randomly distributed
throughout the domain. A vector ﬁeld describing the ﬁber
directions modulates the migration velocity of the ECs in the
presence of ﬁbers.
Molecular species, cells, cell densities, and matrix prop-
erties are deﬁned in Table 1.
Model equations
In the following, we state the governing equations of the
model, along with the assumptions that they implement. The
assumptions are identiﬁed by acronyms (V1) for VEGF
through (ECM3) for the ECMwhile they are referenced using
fV1g.
Vascular endothelial growth factors
VEGF is implicated as a key regulator of pathological, tumor-
induced angiogenesis (10). In this work we assume a source
of soluble VEGF (sVEGF), thus implicitly modeling its re-
lease from tumor cells (V1). We consider in addition VEGF
FIGURE 1 Conceptual sketch of the different VEGF isoforms present in
the ECM. Soluble and cleaved VEGF isoforms freely diffuse through the
ECM, whereas matrix-bound VEGF isoforms stick to the ﬁbrous structures
composing the ECM and can be cleaved by MMPs secreted by the sprout
tips.
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isoforms that bind to the ECM matrix-bound VEGF
(bVEGF) (V2).
Matrix-bound VEGF [bVEGF]. Matrix-bound VEGF
(bVEGF) does not diffuse and it is assumed to be locally
distributed in the ECM (25,59) (V3). On initialization,
bVn spherical clusters of bound VEGF with radius bVr and
VEGF level bVl are distributed in the domain. The spheres
have a smooth interfacemolliﬁed by aGaussian function. The
matrix-bound VEGF is then multiplied with the matrix indi-
cator ﬁeldEx tomodelVEGFbinding to thematrix ﬁbers. The
bVEGF can be cleaved from the matrix by MMPs released
from migrating ECs (24) (V4). Endothelial cells express sur-
face receptors that bind VEGF molecules (60), thus enabling
the migrating tip cells to sense the VEGF concentration in
their vicinity and to trigger chemotaxis (14) (V5).
Matrix-bound VEGF evolution is given by
@½bVEGF
@t
¼ ybV½MMP½bVEGF; (1)
with the cleaving rate ybv fV4g.
Cleaved VEGF [cVEGF]. Cleaved bVEGF (cVEGF) dif-
fuses through the ECM (V6). Cleaved VEGF as well as sol-
uble VEGF are subject to natural decay (V7), with the decay
rate given by dV.
@½cVEGF
@t
¼ kV=2½cVEGF1 ybV½MMP½bVEGF
 yV½cVEGFr  dV½cVEGF; (2)
with the endothelial uptake rate of VEGF given by yv and the
endothelial cell density r fV5g.
Soluble VEGF [sVEGF]. Upon release fV1g, the soluble
VEGF proteins diffuse through the ECM and establish a
chemotactic gradient (V8). Soluble VEGF is subject to en-
dothelial uptake and decay fV5, 7g. The diffusion constant is
given by parameter kV:
@½sVEGF
@t
¼ kV=2½sVEGF yV½sVEGFrdV½sVEGF: (3)
Fibronectin
Fibronectin is a protein binding to cell integrin receptors and
to extracellular matrix components (18).
Unbound ﬁbronectin [FIB]. Depending on its local con-
centration, ﬁbronectin is released by the migrating ECs (17)
(F1). We consider ﬁbronectin released by ECs binding to
integrins located at the EC membrane (F2) and to matrix
components such as collagen and ﬁbrin, establishing an ad-
hesive force between cells and ﬁbers in the ECM (18)(F3).
Fibronectin diffuses through the ECMwhen not bound to the
matrix (F4) with a diffusion constant given by kF and is
subject to natural decay (F5). The decay rate for unbound
ﬁbronectin is given by dF,
@½FIB
@t
¼ kF=2½FIB1 gFGðFth; ½FIBÞ½EC
 ybF½FIBðExbFth  ½bFIBÞ  dF½FIB; (4)
with a creation rate gF and creation function
GðCth; ½CÞ ¼ Cth  ½C
Cth
; (5)
depending on the local ﬁbronectin concentration and the
creation threshold level Fth fF1g. The rate of ﬁbronectin
binding to the ECM is given by ybF and bFth is a constant
describing the threshold concentration level for bound ﬁbro-
nectin to account for binding site saturation in the ECM.
Matrix-bound ﬁbronectin [bFIB]. Fibronectin is bound by
the ECM, inhibiting further diffusion fF3g. Bound to the
ECM, ﬁbronectin is degraded by MMPs at the speciﬁc deg-
TABLE 1 Molecular species, cells, cell densities, and matrix
property deﬁnitions
Symbol Description
Equation
or Subsection
[bVEGF] Concentration of matrix-bound VEGF. Eq. 1
[cVEGF] Concentration of cleaved matrix-bound VEGF. Eq. 2
[VEGF] Concentration of soluble VEGF. Eq. 3
[FIB] Concentration of unbound ﬁbronectin. Eq. 4
[bFIB] Concentration of matrix-bound
ﬁbronectin.
Eq. 6
[MMP] Concentration of matrix
metalloproteinases.
Eq. 7
[EC] Endothelial tip cell density. Parameter
Estimation
r Endothelial cell density lining
capillary walls.
Eq. 19
K Vector ﬁeld representing
the ﬁber orientation in the ECM.
ECM
Er Fiber density in the ECM. ECM
Ex Fiber indicator function in the ECM. ECM
FIGURE 2 The ﬁgure shows satellite particles placed in the plane
perpendicular to the sprout migration direction. The values u1–u6 describe
the local migration cues at sprout particle location fB1g.
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radation rate dbF (F6) and decays at a rate given by dbF. The
matrix-bound ﬁbronectin establishes a haptotactic gradient
for the ECs (1)(F7):
@½bFIB
@t
¼ ybF½FIBðExbFth  ½bFIBÞ
 dbF½bFIB½MMP  dbF½bFIB: (6)
Matrix metalloproteinases (MMPs) [MMP]. Matrix met-
alloproteinases (MMPs) are proteases involved in the deg-
radation of matrix proteins and the cleavage of cell surface
receptors. MMPs cleave the bVEGF isoforms from the
binding sites in the ECM (24) (P1). MMPs are assumed to be
released at the migrating ECs depending on the local MMP
concentration (15,27) (P2). The speciﬁc release rate is given
by gM and [EC] describes the endothelial tip cell density.
MMP release is stopped when the local MMP level ap-
proaches the threshold level Mth. Upon release by the ECs,
MMPs are assumed to diffuse through the ECM (P3) with
diffusion constant kM. MMPs are subject to natural decay
(P4). The decay rate is given by dM, and the MMP concen-
tration evolves as
@½MMP
@t
¼ kM=2½MMP1 gMGðMth; ½MMPÞ½EC
 dM½MMP: (7)
Endothelial cells
Endothelial cells are the constituents of blood vessels and have
an active role in sprouting angiogenesis. During angiogenesis,
ECs degrade the blood vessel basement membrane and pro-
liferate in the external matrix, forming eventually new net-
works of blood vessels. ECs are assumed to occur in three
states: quiescent ECs lining regular vessel walls; migrating
cells located at the tip of outgrowing sprouts; and proliferating
ECs located at a small region behind the migrating tip cell.
TABLE 2 Model parameter values
Parameter Description Unit Reference Value
[VEGF]0
[FIB]0 Maximal concentration of molecules. Mol cm
3 (22,34,45) 1013
[MMP]0
[EC]0 Endothelial cell close-packing density. EC cm
3 (12,45) 106
Dl Domain length. cm (22) 1.5 3 10
1
kV VEGF diffusion constant. cm
2 s1 (11,34,45,54) 6 3 107
ybV MMP-VEGF cleaving rate. [VEGF]s
1 cm3 — 2.67 3 108
yV VEGF uptake rate of ECs. [VEGF][EC]
1 s1 (11,54) 2.67 3 1023
dV VEGF decay rate. cm
1 (45,54) 1.8 3 105
kF Fibronectin diffusion constant. cm
2 s1 (34) 3 3 108
gF EC release rate of ﬁbronectin. [FIB][EC]
1 s1 — 3 3 1022
ybF Fibronectin-ECM binding rate. [FIB]
1 s1 — 2.67 3 108
dbF MMP-ﬁbronectin degradation rate. [FIB]
1 s1 — 2.67 3 109
dF Fibronectin decay rate. s
1 — 1.8 3 103
Fth Fibronectin threshold level for creation. [FIB]cm
3 — 1010
dbF ECM bound ﬁbronectin decay rate. s
1 — 1.8 3 105
bFth Maximal ﬁbronectin binding sites in ECM. [FIB]cm
3 — 5 3 1012
kM MMP diffusion constant. cm
2 s1 — 6 3 108
gM EC release rate of MMPs. [MMP][EC]
1 s1 — 3 3 1022
dM MMP decay rate. s
1 — 2.67 3 106
Mth MMP threshold level for creation. [FIB]cm
3 — 1013
wV Chemotactic parameter. cm
5[VEGF]1 s1 — 6 3 105
wV2 Chemotactic coefﬁcient. cm
3[VEGF]1 — 1011
wF Haptotactic parameter. cm
5[FIB]1 s1 — 5 3 1014
l Drag coefﬁcient. — — 0.95
bK ECM strength. — — 0.95
Fbn Number of ﬁber bundles. — — 10
5
Fbl Fiber bundle length. — — 1.17 3 10
2
Fbi Fiber bundle density. — — 1.2
E0 ECM constant. — — 0.05
E1 ECM constant. — — 1.0
C1 ECM constant. — — 4.0
bVn Number of pockets of matrix-bound VEGF. — — 3.7 3 10
3
bVl Level of VEGF in pockets. cm
3[VEGF] — 2.5 3 1014
bVr Radius of VEGF pockets. cm — 1.2 3 10
3
sath Sprout threshold age for branching. d — 2.1
aith Threshold level of anisotropy in ECM for
branching.
— — 15
Qp Endothelial cells density at sprout. cm
3 EC — 106
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Sprout tip migration
The migrating tip cells determine the morphology of the
outgrowing capillaries with proliferating cells ﬁlling the gap
between the established sprout and the migrating tip cell (14)
(M1). The migration direction is determined by chemotactic
fV5g and haptotactic fF2,6g cues in the matrix given by
VEGF and ﬁbronectin gradients (1,10,14) (M2). As the
VEGF level increases in the proximity of the tumor and the
EC surface receptors become occupied, the cells ability to
sense a gradient is affected and the chemotactic cue is at-
tenuated (14,60) (M3). The attenuation is represented by a
function W. The sprout tip acceleration during migration is
deﬁned as
a ¼ aðErÞTðWð½VEGFÞ=½VEGF1wF=½bFIBÞ; (8)
where
Wð½VEGFÞ ¼ wV
11wV2½VEGF; (9)
with chemotactic parameters wV and wV2 and
½VEGF ¼ ½sVEGF1 ½bVEGF1 ½cVEGF: (10)
The presence of ﬁbers (Er) enhances the migration speed
of ECs as the ﬁbers provide integrin receptors promoting
mesenchymal motion of the tip cells (19) (M4). A very dense
matrix slows down the migration speed of the tip cells (13)
(M5) as characterized by the function
aðErÞ ¼ ðE01ErÞðE1  ErÞC1; (11)
where the threshold E0 deﬁnes the migration factor in the
absence of ﬁbers, E1 the maximal ﬁber density, and C1 the
ECM migration constant. The collagen ﬁber bundles com-
posing the ECM provide a guiding structure for ECmigration
(13,19) (M6). To model these directional cues, a tensor T is
introduced acting on the migration velocity,
fTgij ¼ ð1 bðExÞÞf1gij1bðExÞKiKj; (12)
with
bðExÞ ¼ bKEx; (13)
the ECM strength bK andK being the vector ﬁeld the tensor is
applied on.
The particle positions xp are updated according to
@xp
@t
¼ up; @up
@t
¼ ap  lup; (14)
with up and ap being the velocity and acceleration at particle
location xp, and l the drag coefﬁcient.
Branching
Migrating tip cells extend ﬁlopodia equipped with cell sur-
face receptors to sense the surrounding environment for
chemo- and haptotactic cues (14) (B1). The matrix structure
may promote diverging migration directions, leading to
branching of the endothelial tip cells and creation of new
sprouts (25) (B2). In our model, we locate regions of high
anisotropy in the migration acceleration direction ﬁeldV by a
curvature measure k,
kðxÞ ¼ jj
_LðxÞ3 L¨ðxÞjj
jj _Ljj3 ; (15)
with V ¼ ðu; v;wÞ; _LðxÞ ¼ VðxÞ; and L¨ ¼ uVx1vVy1wVz
(61).
FIGURE 3 The ﬁgure shows a conceptional x-z plane through the com-
putational domain. Five sprout tips are initially placed on the y-z plane
lower-end of the domain in x direction; a tumor source of soluble VEGF is
modeled at the upper-end in x direction outside the computational domain.
FIGURE 4 Slice of the [ECM] ﬁeld for ﬁve different densities: (A) 6%, (B) 11%, (C) 26%, (D) 38%, and (E) 75%.
3152 Milde et al.
Biophysical Journal 95(7) 3146–3160
Branching occurs in locations where the local curvature k
exceeds a threshold level aith. To determine the preferred
branching direction in three dimensions, six satellite particles
are distributed radially around the tip cell particle in a plane
perpendicular to the migration direction (Fig. 2) fB1g. The
velocity ﬁeld is measured at these six locations and the angle
between velocities at opposing satellite points is computed.
The branching direction is then deﬁned by the two satellite
particles with the largest angle between velocities pointing
away from the migrating direction. A new tip cell is then
created and to guide the two tip cells apart, the particle
velocity up on the right-hand side of Eq. 14 is changed to u9p,
a combination of the acceleration direction at the satellite and
the direction pointing from the sprout tip position to the
satellite particle position,
u9p ¼ jupj
11b
as
jasj1b
xs  xp
jxs  xpj
 
; (16)
with satellite velocity us at satellite position xs and b ¼ 0.8,
resulting in a short acceleration toward the satellite positions.
ECs are insensitive to branching cues immediately after a
branching event has occurred (1) (B3). To account for this
effect, a sprout threshold age sath is introduced. Sprout tips of
age smaller than sath are not considered for branching.
Anastomosis
Anastomosis, the formation of loops, occurs after the sprout
tips have migrated some distance into the ECM and
branching has taken place (1). Tip cells fuse either with
existing sprouts or with other tip cells (A1). When a sprout
tip fuses with an existing sprout, a loop is closed and mi-
gration stops for the sprout tip (A2). When two sprout tips
fuse, a loop is closed and migration is stopped for both tip
cells (A3).
ECM
The ECM consists of ﬁbrous structural glycoproteins such as
collagens, elastin, and laminin, giving the ECM structure,
strength, and resistance (13,29) (ECM1). Collagens are the
main component of the ECM in humans and cross link with
neighboring collagens to form bundles (19) (ECM2). Other
components present in the ECM are cell-matrix adhesion
promoting proteins such as ﬁbrin and ﬁbronectin, interstitial
ﬂuids like blood plasma, and various growth factors such as
VEGF (13) (ECM3).
In this work, the ECM is modeled as a collection of ﬁber
bundles randomly distributed throughout the computational
domain fECM1,2g. The ECM is represented by three grid-
functions: 1), a vector ﬁeld K that describes the ﬁber orien-
tations; 2), a smooth indicator function Ex, indicating the
presence of ﬁbers at any given point in space; and 3), a ﬁber
density ﬁeld Er, which is used to regulate migration speed
according to fM4,6g.
These ﬁelds are constructed in a straightforward manner by
generating Fbn random ﬁbers with a given length Fbl, which
is constant for all ﬁbers. These ﬁbers are then put on the grid
much like lines are rasterized in computer graphics (62). In the
case of K, the directions are rasterized onto the grid, and in
the case of Ex, we tag the grid points at the ﬁber locations with
a value of 1, resulting in randomly distributed ﬁbers.
The ﬁelds K and Er are ﬁltered with a Gaussian ﬁlter to
achieve a smooth matrix representation. In the case of Ex this
is not possible, so the ﬁeld is constructed by using smoothed
ﬁbers. In cases where ﬁbers overlap, the maximum value of
the two ﬁbers is retained.
METHODS
The time-step constraint for diffusion on the molecular species is stricter than
for the reaction part. A fractional step algorithm is used to solve the system
efﬁciently. In this algorithm the nonlinear and linear reaction parts of the
equations are solved simultaneously using explicit Euler steps. The linear
diffusion part is solved using implicit time steps. The systems can be safely
decoupled, as EC cell migration occurs on a much smaller timescale than
molecular diffusion and steady state can be assumed for the source and sink of
the different proteins. VEGF, ﬁbronectin, and acceleration gradients for mi-
gration velocity and the curvature measure are calculated on the grid using
second-order ﬁnite differences. To get the acceleration and curvature on the
particle at location xp¼ (xp, yp, zp), mesh-particle interpolations are done using
the M94 kernel
Qp ¼ +
ijk
h
3
qijkM94ðxp  ihÞM94ðyp  jhÞM94ðzp  khÞ; (17)
with
M94ðuÞ ¼
1 5juj
2
2
1
3juj3
2
; if 0# juj# 1;
1
2
ð2 jujÞ2ð1 jujÞ; if 1# juj , 2;
0 otherwise;
8>><>>: (18)
with the grid value qijk at grid point [i, j, k] and grid spacing h. To inter-
polate the sprout tip density onto the grid, particle-mesh interpolations are
FIGURE 5 Inﬂuence of the matrix density on the number of branches of
the vessel network (error bars represent standard deviation of data).
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performed using a fourth-order B-spline kernel. In the presence of only one
particle, the B-spline kernel guarantees positive values for [EC] at all grid
locations.
Endothelial cell density
To obtain the endothelial cell density deﬁning the capillary sprouts, at every
time step, we interpolate the sprout tip cell density Qp at xp onto the grid
using a fourth-order B-spline kernel B4 and add the maximum of the inter-
polated sprout tips and the r-ﬁeld onto the r-ﬁeld,
r
n11
ijk ¼ max rnijk;+
p
B4ðih xpÞB4ðjh ypÞB4ðkh zpÞQp
 !
;
(19)
with particle weight Qp, and mesh size h, with n denoting the n
th time
step.
COMPUTATIONAL DETAILS
Parameters
In the development of computational models of angiogene-
sis, a key issue is the estimation of parameters of the gov-
erning equations. Results from biological experiments
provide a range of values for some parameters, such as the
VEGF diffusion coefﬁcient, uptake, and decay rates. On the
other hand no experimental data has been provided so far for
other parameters like MMP cleaving rate, bound VEGF
distribution, and friction coefﬁcient for the endothelial cell
migration. In this article, we formulate the equations in
nondimensional form and then use values for the parameters
as they have been reported in the literature or we infer values
of certain parameters based on parameters for related pro-
cesses. An integrative experimental, computational study to
quantify values for the parameters of our models is the sub-
ject of ongoing research activities.
Nondimensionalizing the parameters
We nondimensionalize the equations by scaling the con-
centrations c of the various substances with a maximum
threshold concentration c0 and the endothelial cell density
[EC] with the close packing cell density [EC]0.
Concentrations:
½bdVEGF ¼ ½bVEGF½VEGF0 ½cdVEGF ¼ ½cVEGF½VEGF0
½sdVEGF ¼ ½sVEGF½VEGF0 ½dFIB ¼ ½FIB½FIB0
½bdFIB ¼ ½bFIB½FIB
0
bFth ¼ Fth½FIB
0cbFth ¼ bFth½FIB0 ½ dMMP ¼ ½MMP½MMP0bMth ¼ Mth½MMP0 ½cEC ¼ ½EC½EC0
rˆ
¼ r½EC0 Qˆp ¼
Qp
½EC0
:
(20)
Further, we scale the distance with the domain size Dl, and
time withD2l =kV;where kV is the VEGF diffusion coefﬁcient.
Space and time:
tˆ ¼ kVt
D
2
l
lˆ ¼ l
Dl
: (21)
Rescaling our set of parameters, we obtain the nondimen-
sionalized set of parameters.
FIGURE 6 Capillary networks for different ECM densities: 6% (A), 11% (B), 26% (C), 38% (D), and 75% (E).
FIGURE 7 Effect of ﬁbronectin weight wF on branch lengths: mean
branch length at t ¼ 20.0 (error bars indicate standard deviation of data).
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Model parameters:
kˆV ¼ kV
kV
yˆV ¼ yV½EC0D
2
l
kV
dˆV ¼ dVD
2
l
kV
yˆbV ¼ ybV½MMP0 D
2
l
kV
dˆbV ¼ dbVD
2
l
kV
kˆF ¼ kF
kV
gˆF ¼ gF½EC0D
2
l
kV½FIB0
dˆF ¼ dFD
2
l
kV
yˆbF ¼ ybFD
2
l
kV
dˆbF ¼ dbF½MMP0D
2
l
kV
dˆbF ¼ dbFD
2
l
kV
kˆM ¼ kM
kV
gˆM ¼ gM½EC0D
2
l
kV½MMP0
dˆM ¼ dMD
2
l
kV
wˆV ¼ wV½VEGF0
kV
wˆV2 ¼ wV2½VEGF0
wˆF ¼ wF½FIB0
kV
(22)
Parameter estimation
Table 2 shows the estimated values of parameters in our
model. These estimates were based on experimental data
reported in the references. When no reference measurements
were available, the parameters were estimated on data given
for similar species. For model parameters such as the drag
coefﬁcient l, anisotropy threshold level aith, or the ECM
strength bK, parameters were chosen to suit the model.
Model parameter values
We use the estimates from the table above to deﬁne our
nondimensional set of model parameters. Model parameters
that are dimensionless will be assigned to the value deﬁned in
the table. For ease of understanding, we drop the hats from
the notation of the nondimensional variables and from now
on only refer to nondimensional variables:
kV ¼ 1:0 ybV ¼ 100:0 yV ¼ 0:0 dV ¼ 0:675
kF ¼ 0:05 tgF ¼ 113:0 dF ¼ 67:5
ybF ¼ 1:0 dbF ¼ 10:0 dbF ¼ 0:675
kM ¼ 0:1 gM ¼ 113:0 dM ¼ 0:1
bFth ¼ 0:5 Fth ¼ 0:001 Mth ¼ 1:0
wV ¼ 0:1 wV2 ¼ 0:5 wF ¼ 0:001
Dl ¼ 1:0 Fbl ¼ 10:0 sath ¼ 5:0 aith ¼ 15:0
bVl ¼ 0:25 bVr ¼ 0:008 Qp ¼ 1:0
:
(23)
The results reported in the article are based on simulations
using the above values unless stated otherwise.
Initial and boundary conditions
The computational domain is deﬁned as a cube of size D3l
discretized with a 1283 uniform grid. In the following, we set
Dl ¼ 1 and all spatial dimensions are appropriately normal-
ized. A source of VEGF, representing a tumor, is distributed
on the y-z plane at x ¼ 1, which is at the boundary of the
domain. Five vessel sprouts are initially placed along a line at
z ¼ 0.5 on the y-z plane at x ¼ 0.0. The locations of the
sprouts are at y ¼ 0.15625, 0.3125, 0.46875, 0.625, and
0.78125 (see Fig. 3).
The tumor source of VEGF is modeled via a Dirichlet
boundary condition in the x direction for the governing
equations of the soluble VEGF, with [sVEGF] ¼ 1.0 at x ¼
1.0 and [sVEGF] ¼ 0.0 at x ¼ 0.0. For all other concentra-
tions, we apply homogenous Neumann boundary conditions
in the x direction. In y and z directions we apply periodic
boundary conditions for all molecular species. Matrix-bound
FIGURE 8 Effect of ﬁbronectin weight wF on the number of vessel
branches: average number of branches at t ¼ 20.0 (error bars indicate
standard deviation of data).
FIGURE 9 Effect of cell-cell haptotaxis (wF) on the
vessel network morphology: wF ¼ 0.001 (A), wF ¼ 0.125
(B), and wF ¼ 1.0 (C).
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VEGF is distributed throughout the domain equally in y and z
directions with an increased concentration toward the
boundary at x ¼ 1, accounting for the tumor as a source of
VEGF. The distribution is given by
x
y
z
0@ 1A ¼ 0:11 0:9 ﬃﬃﬃﬃr1pr2
r3
0@ 1Awith r1; r2; r3 u: a: r½0; 1: (24)
For the capillary sprouts, we apply periodic boundary con-
ditions in y and z dimension. Sprouts leaving the domain in x
direction are eliminated from the simulation. We note that
periodic boundary conditions in the y and z dimensions imply
homogeneity of the process in these directions. The use of
FIGURE 10 Effect of ﬁbronectin weight wF on the probability of branch
fusion events at t ¼ 20.0 (error bars indicate standard deviation of data). FIGURE 11 Effect of number of VEGF pockets bVn on the number of
branches (error bars indicate standard deviation of the data). The horizontal
line denotes the average number of branches for the case of no bound-
VEGF; the dashed lines represent the standard deviation for that case.
FIGURE 12 Effect of MMPs cleaving matrix-bound
VEGF on chemotactic cues and anisotropy at pocket
location for bVn ¼ 3700 and bVl ¼ 0.25: t ¼ 13.21 (A),
t¼ 16.89 (B), and t¼ 20.63 (C). The white cloud in the left
ﬁgure denotes the MMP concentration; the orange dots
indicate pockets of matrix-bound VEGF. The ﬁgure in the
middle shows the evolution of the acceleration ﬁeld at
pocket location (see also Movie S1).
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periodic conditions can be justiﬁed when phenomena from
the image domains do not interfere with the process of
angiogenesis in the main domain. This is indeed the case in
these simulations for the times that have been simulated.
RESULTS
We report results on the blood vessel morphology as inﬂu-
enced by large-scale parametric studies of the structure of the
ECM, the distribution of matrix-bound VEGF, and the in-
tensity of cell-cell and cell-matrix adhesion. These three-di-
mensional simulations are novel as they include explicitly
soluble and bound growth factors, they account for the ﬁ-
brous structure of the ECM and its binding sites for ﬁbro-
nectin, and they investigate their effects on guidance cues and
endothelial cell migration. We present statistics of the
branching points, branch lengths and frequency of anasto-
mosis providing a quantitative, comparative analysis that
may guide future experiments and simulations. SeeMovie S2
for a video of the simulation.
Matrix structure
We ﬁrst assess the effects of the ECM density on the resulting
vessel networks. Random ﬁber ﬁelds were created with ﬁve
different densities: 15,000 ﬁbers resulting in a volume den-
sity of 6%; 30,000 ﬁbers (11%); 70,000 ﬁbers (26%);
100,000 ﬁbers (38%); and 200,000 ﬁbers (75%) (Fig. 4). The
normalized volume density is given by the sum of the ﬁber
density Er over all grid points divided by the number of grid
points. For each density value we performed 32 simulations
with a different random seed for the ﬁber placement. If not
stated otherwise, all results presented herein are ensemble
averages over these 32 instances. Comparing the number of
branches found in the computational domain at T¼ 22.0 (Fig.
5), we ﬁnd a linear increase of the number of branches for
logarithmic increasing ﬁber density up to a threshold density
at ;40%. After this point, the number of branches can be
observed to decrease again. Examples of the structure of the
corresponding vessel networks are depicted in Fig. 6: in very
low density ECMs, hardly any branching occurs, while in
very dense ECMs the EC sprouts branch very often. In the
75% density case the ﬁber density is high enough to impair
the migration which leads to shorter capillary networks (Fig.
6 E).
Haptotaxis
We investigated the effect of the weight of the haptotactic
cues. We performed simulations with six different values for
FIGURE 13 Effect of VEGF level bVl on the number of branches (error
bars indicate standard deviation of the data). The horizontal line denotes the
average number of branches for the case of no bound-VEGF; the dashed
lines represent the standard deviation for that case.
FIGURE 14 Histogram of branch lengths for no bound VEGF (open
bars), and 100,000 VEGF pockets (shaded bars).
FIGURE 15 Relationship between the average number of branches and
the probability of anastomosis: varying the number of bound-VEGF pockets
(solid circles), and increasing haptotaxis (open circles).
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wF (0.001, 0.005, 0.025, 0.125, 0.25, 0.5, and 1.0) in an ECM
with a ﬁber density of 26%. We found no discernible effects
on the length of the vessel branches (Fig. 7). As haptotactic
cues become stronger the average number of branches in a
vessel network is greatly reduced (Fig. 8). The reason for this
behavior becomes evident when we inspect the morphology
of the vessel networks (Fig. 9 ): we observe that an increased
inﬂuence of ﬁbronectin (i.e., increased values of wF), results
in narrower networks and an increased frequency of anasto-
mosis (Fig. 10) Haptotaxis essentially represents a very lo-
calized autocrine directional cue, and thus serves as a
recruiter for neighboring vessels.
Matrix-bound VEGF
To investigate the effect of matrix-bound VEGF we per-
formed simulations with a decreased threshold age for
branching of sath ¼ 4 and an increased branching threshold
level of anisotropy aith ¼ 45. The model parameters gov-
erning the MMP evolution are set to: kM ¼ 0.01, gM ¼ 250,
and dM ¼ 100 and haptotaxis is switched off: wF ¼ 0.0. In a
ﬁrst set of simulations, we varied the amount of matrix-bound
VEGF, distributing 500, 1400, 3700, and 10,000 pockets
holding a VEGF level of bVl ¼ 0.25. With an increased
number of pockets, we observed an increase in the number of
branches (Fig. 11). The pockets induce strong chemotactic
cues (Fig. 12). The probability of sprout tips hitting a pocket
is increased for a higher pocket density, leading consequently
to an increase in branching.
In a second set of simulations, we varied the VEGF level,
comparing runs with 3700 pockets containing a VEGF level
of bVl ¼ 0.01, 0.03, 0.09, and 0.25 (Fig. 13). We observe an
increase in branching along with an increase in the VEGF
level. The results show that not only the density of bound
VEGF but also the pocket level has an effect on branching
behavior. This is attributed to the MMPs cleaving the matrix-
bound VEGF, effectively reducing the chemotactic cues to-
gether with the level of anisotropy at pocket location (Fig.
12). As pockets are being cleaved before the sprout tips reach
them, their inﬂuence on the branching and migration be-
havior is reduced. For pockets with a low VEGF level, the
cleaving removes most VEGF from the pocket before the
sprout tips get there, making the inﬂuence of bound VEGF
dependent on the level of the pocket.
Comparing branch lengths in the absence of bound VEGF
to the case of 100,000 distributed pockets (Fig. 14), no sig-
niﬁcant variation is observed in the mean branch length. The
distributions of the two settings however vary considerably,
leading to a narrower distribution in the branch length for the
simulations including bound VEGF.
Investigating the probability of anastomosis, we found an
increase in the number of sprout fusions for an increasing
number of pockets distributed (Fig. 15 ). Note that a similar
effect has been observed for an increase in the weight of
haptotactic cues. Comparing, however, the probability of
anastomosis against the number of branches, we ﬁnd that
matrix-bound VEGF has quite an opposite effect on the fu-
sion probability than the haptotactic cues. Themorphology of
the vessels (Figs. 16 and 17) indicates that the distributed
VEGF introduces deviation in the migration of sprout tips
toward pocket location, whereas the haptotactic cues intro-
duce directed deviation toward existing sprouts (Fig. 9).
CONCLUSIONS
We presented a three-dimensional model of sprouting angi-
ogenesis that incorporates for the ﬁrst time, to the best of our
knowledge, effects of the extracellular matrix structure on the
vessel morphology and considers both soluble and matrix-
bound growth factor isoforms.
FIGURE 16 Effect of pocket number
of matrix-bound VEGF (bVn) on the
vessel network morphology: bVn ¼
500 (A), bVn ¼ 1400 (B), bVn ¼ 3400
(C), and bVn ¼ 10,000 (D).
FIGURE 17 Evolution of angioegenesis (red) in the
presence of matrix-bound VEGF (blue). Bound VEGF is
cleaved by MMPs (not shown) (see also Movie S3).
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The model is used to perform large-scale parametric
studies to assess the vessel morphology as inﬂuenced by the
structure of the ECM, the distribution of matrix-bound
VEGF, and the intensity of cell-cell and cell-matrix adhesion.
The simulations demonstrate that the structure and density of
the ECM has a direct effect on the morphology, expansion
speed, and number of branches observed in computationally
grown vessel networks. The simulations reﬂect the inﬂuence
of the extracellular matrix composition on endothelial cell
migration and network formation corresponding to obser-
vations made by the literature (13,18,19). Simulation results
presented for sprouting angiogenesis in the presence of ma-
trix-bound VEGF isoforms demonstrate an increase in the
number of observed branches for an increase in both the
amount of distributed VEGF pockets and the level of VEGF
at pocket location. In addition, a strong effect on the sprout
morphology can clearly be observed. These results are con-
sistent with the ﬁndings made by the literature (24,25) on
sprouting angiogenesis in the presence of matrix-bound
VEGF. With the number of branches depending on the
matrix structure and level of matrix-bound VEGF isoforms,
this model may be easier to tune against experiments com-
pared to most other models where branching is modeled as a
purely probabilistic process.
The method is formulated as a generalized particle method
and is implemented upon a parallel particle-mesh framework
(63); this renders the method scalable to massively parallel
computer architectures, a crucial aspect for the study of
angiogenesis at macroscopic scales, and integrative models
of vascular tumor growth. The grid-independent particle
representation of migrating tip cells provides a way to gen-
erate smooth vessel networks. Particle-to-mesh and mesh-to-
particle interpolation schemes provide a straightforward way
of coupling the two levels of representation. Limitations of
the current model are related to the explicit deﬁnition of tip
cells restricting the formation of new sprout tips to predeﬁned
locations on the initial vasculature. After initiation, new
sprout tips can only emerge from branching migrating tip
cells. Formulation of a tip cell selection method combined
with cell-type-speciﬁc migration and proliferation rules are
the subject of current work. We are currently working on
addressing these limitations and on developing methods for
vessel maturation and simulations of blood ﬂow through the
matured networks. The integration of this framework in
studies of tumor-induced angiogenesis is a subject of coor-
dinated investigations with experimental groups.
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